{"id":"treatment-experienced-patients-mndl-therapy","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MNDL appears to be a multi-drug regimen developed by the National Liver Institute in Egypt for patients who have failed prior hepatitis C treatments. The exact composition and mechanism are not clearly defined in available literature, but such regimens typically employ direct-acting antivirals (DAAs) targeting viral protease, polymerase, or NS5A proteins to inhibit viral replication and achieve sustained virologic response.","oneSentence":"MNDL therapy is a treatment regimen for treatment-experienced hepatitis C patients, likely combining antiviral agents to target viral replication and clearance.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:14:10.902Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-experienced hepatitis C virus (HCV) infection"}]},"trialDetails":[{"nctId":"NCT05184491","phase":"PHASE4","title":"Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management","status":"UNKNOWN","sponsor":"National Liver Institute, Egypt","startDate":"2021-10-15","conditions":"Helicobacter Pylori","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Treatment-experienced patients- MNDL therapy","genericName":"Treatment-experienced patients- MNDL therapy","companyName":"National Liver Institute, Egypt","companyId":"national-liver-institute-egypt","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MNDL therapy is a treatment regimen for treatment-experienced hepatitis C patients, likely combining antiviral agents to target viral replication and clearance. Used for Treatment-experienced hepatitis C virus (HCV) infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}